Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically.
Subscribe Today
In this week’s Pathways Picks: AdvaMed provides detailed input to Capitol Hill on AI policy priorities; the UK launches an AI medical device sandbox; EU’s device policy group meets; notified body resources increase; China updates risk classification procedures; FDA joins reimbursement panels, and addresses device remanufacturing; and more.
In this week’s Pathways Picks: AdvaMed provides detailed input to Capitol Hill on AI policy priorities; the UK launches an AI medical device sandbox; EU’s device policy group meets; notified body resources increase; China updates risk classification procedures; FDA joins reimbursement panels, and addresses device remanufacturing; and more.
In this week’s Pathways Picks: AdvaMed provides detailed input to Capitol Hill on AI policy priorities; the UK launches an AI medical device sandbox; EU’s device policy group meets; notified body resources increase; China updates risk classification procedures; FDA joins reimbursement panels, and addresses device remanufacturing; and more.